CRISPR-based electrochemical biosensors: an alternative for point-of-care diagnostics?

Autor(es)

Wachholz Junior, Dagwin ; Kubota, Lauro Tatsuo

• Tipo de documento: Artigo Científico
• Fonte: Talanta; v. 278, p. 18-pg., 2024-07-04.

Resumo

The combination of CRISPR technology and electrochemical sensors has sparked a paradigm shift in the landscape of point-of-care (POC) diagnostics. This review explores the dynamic convergence between CRISPR and electrochemical sensing, elucidating their roles in rapid and precise biosensing platforms. CRISPR, renowned for its remarkable precision in genome editing and programmability capability, has found a novel application in conjunction with electrochemical sensors, promising highly sensitive and specific detection of nucleic acids and biomarkers associated with diverse diseases. This article navigates through fundamental principles, research developments, and applications of CRISPR-based electrochemical sensors, highlighting their potential to revolutionize healthcare accessibility and patient outcomes. In addition, some key points and challenges regarding applying CRISPR-powered electrochemical sensors in real POC settings are presented. By discussing recent advancements and challenges in this interdisciplinary field, this review evaluates the potential of these innovative sensors as an alternative for decentralized, rapid, and accurate POC testing, offering some insights into their applications across clinical scenarios and their impact on the future of diagnostics. (AU)

• Processo FAPESP: 14/50867-3 - INCT 2014: Instituto Nacional de Ciência e Tecnologia de Bioanalítica
• Beneficiário: Marco Aurelio Zezzi Arruda
• Modalidade de apoio: Auxílio à Pesquisa - Temático
• Processo FAPESP: 13/22127-2 - Desenvolvimento de novos materiais estratégicos para dispositivos analíticos integrados
• Beneficiário: Lauro Tatsuo Kubota
• Modalidade de apoio: Auxílio à Pesquisa - Temático
• Processo FAPESP: 21/09706-0 - Desenvolvimento de biossensor eletroquímico baseado na tecnologia CRISPR/Cas para detecção do vírus causador da Leucemia de Células T (HTLV-1) e da bactéria Staphylococcus aureus a partir de dispositivos point-of-care
• Beneficiário: Dagwin Wachholz Júnior
• Modalidade de apoio: Bolsas no Brasil - Doutorado